The global preimplantation genetic testing (PGT) market was valued at approximately USD 802.2 million in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 10.3% from 2024 to 2030. Several factors are contributing to this growth, notably the rising prevalence of genetic disorders such as single gene, mitochondrial, and other hereditary conditions. As awareness...

The global real-time PCR, digital PCR, and end-point PCR market size is expected to reach USD 7.18 billion by 2030, registering a CAGR of 4.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. However, the real global real-time PCR, digital PCR, and end-point PCR market without the impact of the COVID-19 pandemic is expected to expand at a compound annual...

The global genetic testing market size is anticipated to reach USD 39.25 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 22.5% from 2025 to 2030. The growth of the genetic testing industry is majorly attributed to the rising prevalence of genetic conditions, increasing investments in R&D, and initiatives by...

The global in-vitro toxicology testing market size is expected to reach USD 64.81 billion by 2030, registering a CAGR of 11.17% from 2024 to 2030, according to a new report by Grand View Research, Inc. Over the years, acceptance of in-vitro toxicology testing methods by regulatory authorities is increasing at a faster pace & thus validation of these tests methods opposed to...

The global non invasive prenatal testing market size is expected to reach USD 8.16 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 10.06% from 2024 to 2030. Increasing incidence of chromosomal abnormalities is expected to accelerate market growth. Of all the countries, there is a substantial opportunity in China for non invasive prenatal...

Preimplantation Genetic Testing Industry The global preimplantation genetic testing market size is expected to reach USD 1.54 billion by 2030, growing at 10.3% CAGR from 2024 to 2030, as per the new report by Grand View Research, Inc. Recent technological advancements in testing have changed the current practice of prenatal screening and early detection of chromosomal...

Preimplantation Genetic Testing Industry The global preimplantation genetic testing market size was estimated at USD 802.2 million in 2023 and is expected to grow at a CAGR of 10.3% from 2024 to 2030. The growing prevalence of single gene, mitochondrial, and other genetic disorders is expected to drive the demand for preimplantation diagnosis and screening processes in the coming years. The...

The global preimplantation genetic testing (PGT) market was estimated to be valued at USD 802.2 million in 2023, with projections indicating a compound annual growth rate (CAGR) of 10.3% from 2024 to 2030. This growth is largely driven by the increasing prevalence of single-gene, mitochondrial, and other genetic disorders, which is anticipated to elevate the demand for preimplantation...

The global urinalysis market size is expected to reach USD 3.07 billion by 2030, expanding at a CAGR of 4.7% from 2023 to 2030, according to a new report by Grand View Research, Inc. Increasing incidence of UTI worldwide contributes to market growth. According to a study published by SHEA journal, in 2021, approximately 60% to 70% of urinalyses were being performed in patients without symptoms...